These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 13779690)

  • 1. [Peripheral actions and central actions of reserpine from the pharmacological and therapeutic viewpoint].
    VALDECASAS FG; SALVA JA
    Arch Med Exp; 1960; 23():363-9. PubMed ID: 13779690
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacology of p-chloro-alpha-(2-dimethylaminoethoxy)-benzylpyridine. I. Antihistaminic action and effect on the peripheral and central nervous system].
    CAHEN R
    Ann Pharm Fr; 1962 May; 20():463-7. PubMed ID: 13875551
    [No Abstract]   [Full Text] [Related]  

  • 3. [Morphological changes in the central and peripheral nervous system under the influence of aminazine in relation to age].
    CHAIKA EI; KOZACHUK IuS
    Fiziol Zh; 1962; 8():368-74. PubMed ID: 13877860
    [No Abstract]   [Full Text] [Related]  

  • 4. [On some features of the changes of the functional state of the central nervous system in experimental tetanus and the mechanisms of action of tetanus toxin. Part III. On the central and peripheral action of tetanus toxin].
    KRYZHANOVSKII GN
    Biull Eksp Biol Med; 1960 Jan; 49():42-8. PubMed ID: 14412353
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of chlorpromazine and reserpine on the central actions of morphine in the cat.
    QUINN G; BRODIE BB
    Med Exp Int J Exp Med; 1961; 4():349-55. PubMed ID: 14489501
    [No Abstract]   [Full Text] [Related]  

  • 6. Reserpine action on the central nervous system of the cat.
    HAMEL EG; KAELBER WW
    Am J Physiol; 1961 Feb; 200():195-200. PubMed ID: 13710985
    [No Abstract]   [Full Text] [Related]  

  • 7. [Reversibility of changes caused by prolonged use of therapeutic and subtoxic doses of reserpine (experimental-morphological study)].
    MATVEEV VF
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1961; 61():1871-6. PubMed ID: 14471471
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction of nicotinamide with reserpine and chlorpromazine. II. Some effects on the central nervous system of the mouse.
    BURTON RM; SALVADOR RA; GOLDIN A; HUMPHREYS SR
    Arch Int Pharmacodyn Ther; 1960 Nov; 128():253-9. PubMed ID: 13689296
    [No Abstract]   [Full Text] [Related]  

  • 9. [Modification of the tranquilizing effect of reserpine and an analysis of its central effect].
    KNOLL J; KNOLL B
    Kiserl Orvostud; 1961 Oct; 13():457-67. PubMed ID: 14457306
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the subject of the permeability behavior of the CNS under the effect of reserpine and orphenadrine].
    LIEBALDT G
    Med Esp; 1960; 2():377-80. PubMed ID: 13761977
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of the chronic administration of reserpine on the genital function of the male rat. Changes in sex behavior, the genital tract and central nervous system changes].
    SOULAIRAC A; SOULAIRAC ML
    Ann Endocrinol (Paris); 1962; 23():281-92. PubMed ID: 13915397
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of therapeutic and subtoxic doses of serpasil on the brain and internal organs of animals in chronic experimental conditions].
    MATVEEV VF
    Arkh Patol; 1961; 23(12)():28-33. PubMed ID: 14471472
    [No Abstract]   [Full Text] [Related]  

  • 13. Discussion: Pavlovian Conference on Higher Nervous Activity. III. Deviance and drugs.
    KILLAM KF
    Ann N Y Acad Sci; 1961 Jul; 92():1031-3. PubMed ID: 13755949
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the relationship between central and peripheral cholinolytic effects of certain complex esters of diethylaminoethanol and aromatic acids].
    DENISENKO PP
    Biull Eksp Biol Med; 1961 Mar; 51():72-6. PubMed ID: 13721869
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of resperine on the functional state of the higher nervous centers in patients with hypertension].
    KARAKULINA TT
    Tr Leningr Sanitarnogig Med Inst; 1959; 48():192-6. PubMed ID: 13853253
    [No Abstract]   [Full Text] [Related]  

  • 16. Do ganglion-blocking agents and reserpine affect central vasomotor activity?
    McCUBBIN JW; PAGE IH
    Circ Res; 1958 Nov; 6(6):816-24. PubMed ID: 13585611
    [No Abstract]   [Full Text] [Related]  

  • 17. [Does reserpine stimulate the medullary vasomotor centers?].
    Donnet V; Duflot JC; Jacquin M; Peyrot J; Fornaris M
    Pathol Biol (Paris); 1969 Dec; 17(23):1079-82. PubMed ID: 4908014
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemicholiniums: structure activity relationships and actions on the peripheral nervous system.
    LONG JP
    Fed Proc; 1961 Jul; 20():583-6. PubMed ID: 13763331
    [No Abstract]   [Full Text] [Related]  

  • 19. The decarboxylation of amino acids related to tyrosine and their awakening action in reserpine-treated mice.
    BLASCHKO H; CHRUSCIEL TL
    J Physiol; 1960 May; 151(2):272-84. PubMed ID: 13801347
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of serpasil on the functional state of the central nervous system].
    MALECKI I
    Acta Physiol Pol; 1959; 10():729-31. PubMed ID: 14420257
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.